{"AllianceGenome": "6763", "HGNC": "6763", "MIM": "601467", "_id": "4085", "_version": 1, "accession": {"genomic": ["AB056160.1", "AC097173.1", "AH010660.2", "AY456198.1", "CH471056.2", "CP068274.2", "NC_000004.12", "NC_060928.1"], "protein": ["AAH00356.1", "AAH05945.1", "AAH70283.1", "AAK38174.1", "AAN74648.1", "AAY40945.1", "BAB63410.1", "BAD97153.1", "BAG36562.1", "BAG60497.1", "CAA03943.1", "EAX05270.1", "EAX05271.1", "EAX05273.1", "NP_002349.1", "Q13257.1"], "rna": ["AA443733.1", "AF394735.1", "AJ000186.1", "AK223433.1", "AK298228.1", "AK313827.1", "BC000356.2", "BC005945.1", "BC070283.1", "NM_002358.4"], "translation": [{"protein": "CAA03943.1", "rna": "AJ000186.1"}, {"protein": "AAN74648.1", "rna": "AF394735.1"}, {"protein": "AAH70283.1", "rna": "BC070283.1"}, {"protein": "NP_002349.1", "rna": "NM_002358.4"}, {"protein": "BAD97153.1", "rna": "AK223433.1"}, {"protein": "AAH00356.1", "rna": "BC000356.2"}, {"protein": "BAG60497.1", "rna": "AK298228.1"}, {"protein": "BAG36562.1", "rna": "AK313827.1"}, {"protein": "AAH05945.1", "rna": "BC005945.1"}]}, "alias": ["HSMAD2", "MAD2"], "ensembl": {"gene": "ENSG00000164109", "protein": ["ENSP00000296509", "ENSP00000332295", "ENSP00000425702"], "transcript": ["ENST00000296509", "ENST00000333047", "ENST00000504707", "ENST00000511295", "ENST00000512484"], "translation": [{"protein": "ENSP00000296509", "rna": "ENST00000296509"}, {"protein": "ENSP00000332295", "rna": "ENST00000333047"}, {"protein": "ENSP00000425702", "rna": "ENST00000504707"}], "type_of_gene": "protein_coding"}, "entrezgene": "4085", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 7.7306693559, "exp_mis": 71.3338395076, "exp_syn": 30.1911839815, "lof_z": 1.32913141554326, "mis_z": 1.35130963148781, "mu_lof": 5.3032953832e-07, "mu_mis": 6.41748724516e-06, "mu_syn": 2.61877164417e-06, "n_lof": 4.0, "n_mis": 48.0, "n_syn": 27.0, "p_li": 0.0131674546651585, "p_null": 0.125348707851981, "p_rec": 0.861483837482861, "syn_z": 0.360048264677041}, "bp": 618, "cds_end": 120987889, "cds_start": 120981272, "n_exons": 5, "nonpsych": {"exp_lof": 6.89946907772, "exp_mis": 64.4664775303, "exp_syn": 27.2284019678, "lof_z": 1.08408316407354, "mis_z": 1.47415331003331, "mu_lof": 5.3032953832e-07, "mu_mis": 6.41748724516e-06, "mu_syn": 2.61877164417e-06, "n_lof": 4.0, "n_mis": 41.0, "n_syn": 24.0, "p_li": 0.0103371211470702, "p_null": 0.183868853877349, "p_rec": 0.80579402497558, "syn_z": 0.389528968811468}, "nontcga": {"exp_lof": 7.10270916103, "exp_mis": 65.6176301475, "exp_syn": 27.7663832655, "lof_z": 1.51858790835359, "mis_z": 1.39106253055077, "mu_lof": 5.3032953832e-07, "mu_mis": 6.41748724516e-06, "mu_syn": 2.61877164417e-06, "n_lof": 3.0, "n_mis": 43.0, "n_syn": 25.0, "p_li": 0.0567309172127357, "p_null": 0.0769641081727117, "p_rec": 0.866304974614553, "syn_z": 0.332410329846485}, "transcript": "ENST00000296509.6"}, "exons": [{"cdsend": 120066734, "cdsstart": 120060117, "chr": "4", "position": [[120055622, 120060290], [120060873, 120060977], [120061974, 120062095], [120065671, 120065818], [120066661, 120066848]], "strand": -1, "transcript": "NM_002358", "txend": 120066848, "txstart": 120055622}], "exons_hg19": [{"cdsend": 120987889, "cdsstart": 120981272, "chr": "4", "position": [[120976777, 120981445], [120982028, 120982132], [120983129, 120983250], [120986826, 120986973], [120987816, 120988003]], "strand": -1, "transcript": "NM_002358", "txend": 120988003, "txstart": 120976777}], "generif": [{"pubmed": 11907259, "text": "BubR1 and Mad2 act cooperatively to prevent premature separation of sister chromatids by directly inhibiting the anaphase-promoting complex"}, {"pubmed": 11912137, "text": "The steady-state amount of MAD2 inside cells may represent a molecular switch for mitotic checkpoint control."}, {"pubmed": 12351790, "text": "Hec1 was required for the recruitment of Mps1 kinase and Mad1/Mad2 complexes to kinetochores"}, {"pubmed": 12970887, "text": "Defect of spindle checkpoint gene Mad2 and mutation of p53 gene are involved mainly in colorectal carcinogenesis, and cancer/normal tissue ratio >2 is associated with prognosis of colorectal cancer."}, {"pubmed": 15013707, "text": "No apparent selection trend was established with neoplastic progression or aneuploidy for MAD2 in Barrett esophagus."}, {"pubmed": 15024386, "text": "The unusual two-state behavior of Mad2 is critical for spindle checkpoint signaling."}, {"pubmed": 15070740, "text": "Reduction of MAD2 protein levels results in mitotic failure and extensive cell death."}, {"pubmed": 15257285, "text": "p31(comet, formerly known as Cmt2) counteracts the function of Mad2 and is required for the silencing of the spindle checkpoint"}, {"pubmed": 15306814, "text": "Generation of Rb pathway lesions in normal and transformed cells produces aberrant Mad2 expression and mitotic defects leading to aneuploidy, such that elevated Mad2 contributes directly to these defects"}, {"pubmed": 15457580, "text": "Defect of spindle checkpoint gene Mad2 and mutation of p27 gene are involved mainly in colorectal carcinogenesis"}, {"pubmed": 15484292, "text": "Elevation of MAD2 level is present in 74% of gastric cancer patients, and correlates with increased mitotic checkpoint activity but is not associated with patients' aneuploidy and any of the clinicopathological characteristics"}, {"pubmed": 15563594, "text": "reconstitution of Mad2 in Brca1(Delta11/Delta11) cells partially restored the spindle checkpoint and attenuated apoptosis"}, {"pubmed": 15591789, "text": "MAD2 deficiency may cause a mitotic checkpoint defect in hepatoma cells"}, {"pubmed": 16112690, "text": "Frequent mutations of MAD2 in gastric cancers cause defective mitotic spindle checkpoint."}, {"pubmed": 16214181, "text": "Mad2beta is an alternative splicing variant of spindle checkpoint gene mad2, related to drug resistance in gastric cancer cells."}, {"pubmed": 16495226, "text": "high levels of FAT10 protein in cells lead to increased mitotic nondisjunction and chromosome instability, which is mediated by an abbreviated mitotic phase and reduction in the kinetochore localization of MAD2 during prometaphase"}, {"pubmed": 16497171, "text": "Functional analysis suggests that an optimum Mad2 binding efficiency of Cdc20 is required during checkpoint arrest and release"}, {"pubmed": 16714000, "text": "down regulation of MAD2 could promote the drug resistance of gastric cancer cells and inhibit anticancer drugs induced-apoptosis by upregulating Bcl-2 and interfering the mitochondrion apoptosis pathway"}, {"pubmed": 17210994, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17268814, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 17333263, "text": "Kidney papillary carcinoma showed overexpression of MAD2L1."}, {"pubmed": 17498870, "text": "BUB1B mRNA levels but not MAD2L1 levels correlate with intrachromosomal insttability in ductal breast carcinomas."}, {"pubmed": 17621272, "text": "The evidence presented here provides a link between MAD2 inactivation and malignant transformation of epithelial cells."}, {"pubmed": 17934339, "text": "Mad2 is negatively regulated by p31 in heptacellular carcinoma"}, {"pubmed": 17998396, "text": "PRP4 is a spindle assembly checkpoint protein required for MAD2 localization to the kinetochores."}, {"pubmed": 18022367, "text": "Data suggest that the structure of the O-Mad2-C-Mad2 conformational dimer is consistent with a catalytic model in which a C-Mad2 template facilitates the binding of O-Mad2 to Cdc20, the target of Mad2 in the spindle checkpoint."}, {"pubmed": 18022368, "text": "Data suggest that p31(comet)(CMT2) exploits the two-state behavior of Mad2 to block its activation by acting as an \"anti-Mad2.\""}, {"pubmed": 18318601, "text": "Existence of a symmetric Mad2 dimer with Mad1-assisted conformational activation in the spindle checkpoint."}, {"pubmed": 18354482, "text": "REST is degraded by means of the ubiquitin ligase SCF(beta-TrCP) during the G2 phase of the cell cycle to allow transcriptional derepression of Mad2, an essential component of the spindle assembly checkpoint"}, {"pubmed": 18383837, "text": "hBUB1, hBUBR1 and hMAD2 expressions in anaplastic thyroid cancer were significantly higher than those in diffuse cancer. hBUBR1 and hMAD2 expressions in advanced DTCs were significantly higher than those in non-advanced DTCs."}, {"pubmed": 18423499, "text": "No somatic mutations of the Mad2 gene is associated with tumors."}, {"pubmed": 18477210, "text": "Aberrant MAD2 expression is potentially associated with pleomorphic morphology and abnormal mitosis in soft-tissue sarcomas."}, {"pubmed": 18541701, "text": "In human cells, Mps1 catalytic activity is required for spindle checkpoint function and recruitment of Mad2."}, {"pubmed": 18597777, "text": "suggest a novel function of MAD2 by interfering with DNA repair proteins"}, {"pubmed": 18691855, "text": "HsMAD2 and BubR1 were significantly higher in cancer tissue than in adjacent normal tissue (P < 0.01). Tumoral hsMAD2 and BubR1 were significantly decreased after radiochemotherapy"}, {"pubmed": 18712773, "text": "chromosomal binding of the mitotic regulators such as Mad2 is essential for mitotic progression"}, {"pubmed": 18715617, "text": "MAD2 is overexpressed in hepatocellular carcinoma, including high-grade dysplastic nodules and early-stage small hepatocellular carcinoma, indicating that overexpression of MAD2 plays a role in the development and progression of hepatocellular carcinoma."}, {"pubmed": 18852296, "text": "Smurf2 regulates the localization and stability of Mad2."}, {"pubmed": 18953867, "text": "Reduced expression of hsMAD2 gene may be one of the mechanisms inducing numerical chromosome aberration, abnormal embryo development and the occurrence of spontaneous abortion."}, {"pubmed": 18981471, "text": "Tpr regulates Mad1-Mad2 proteins are regulated during the cell cycle and mitotic spindle checkpoint signaling."}, {"pubmed": 19098431, "text": "The degradation of Cdc20 represents a critical control mechanism to ensure inactivation of APC/C(Cdc20) in response to the spindle assembly checkpoint."}, {"pubmed": 19154722, "text": "Results support a model in which immobilized Mad1/Mad2 at kinetochores provides a template for initial assembly of Mad2 bound to Cdc20 that is then converted to a final mitotic checkpoint inhibitor with Cdc20 bound to BubR1."}, {"pubmed": 19261806, "text": "An interaction of tumor-associated N-terminal APC fragments (N-APC) with Mad2, an essential mitotic checkpoint protein, providing a direct molecular support for linking APC mutations to the generation of chromosome instability, is reported."}, {"pubmed": 19276188, "text": "p31(comet) induces tumor cell senescence by mediating p21(Waf1/Cip1) accumulation and Mad2 disruption and that these effects are dependent on a direct interaction of p31(comet) with Mad2."}, {"pubmed": 19461085, "text": "the steady-state amount of MAD2 inside cells may serve as a molecular switch in mitotic checkpoint control and that the subcellular localizations of this spindle protein undergo a shift during malignant transformation"}, {"pubmed": 19620968, "text": "An association between VHL inactivation, reduced Mad2 levels and increased aneuploidy was also found in renal cancer cells, implying that pVHL probably contribute to tumour suppression."}, {"pubmed": 19719327, "text": "A closed-conformation Mad2 template facilitates the binding of open-conformation Mad2 to Cdc20 and supports a mechanism of closed-conformation Mad2-Cdc20 formation away from Mad1-containing kinetochores."}, {"pubmed": 19904549, "text": "results question the role of Plk1-interacting checkpoint helicase in spindle checkpoint (SAC) signaling and identify Mad2 as a sensitive off target for small RNA duplexes/off-target effect on Mad2 may also explain role of Tao1 kinase in SAC signaling."}, {"pubmed": 20007324, "text": "Either overexpression of a key regulator of cell cycle, Mad2, or knock down of Aurora B, an important kinase in mitosis, or Cdh1, a key E3 ligase in cell cycle, resulted in a significant increase of SP cells in CNE-2."}, {"pubmed": 20088965, "text": "hMAD2 also binds to the hREV7-binding sequence in hREV3, whereas hMAD2 does not bind to a similar sequence in ADAM9 or ELK-1 and hREV7 does not bind to the hMAD2-binding sequence in hMAD1 or hCDC20."}, {"pubmed": 20132188, "text": "MAD2 contributes to the pathogenesis and development of human osteosarcoma."}, {"pubmed": 20189264, "text": "Results suggest that LSD1 plays a role in chromosomal segregation during mitosis partially through transcriptional regulation of BUBR1 and MAD2."}, {"pubmed": 20190817, "text": "Data link for the first time ETV6/RUNX1, mitotic checkpoind, and MAD2L1 and provide new insights into the function of the E/R fusion gene product."}, {"pubmed": 20332099, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20440596, "text": "MAD2 could regulate the cell cycle of cancer cells"}, {"pubmed": 20459534, "text": "Aurora A and Mad2 expression was not significantly associated with prognosis after pancreatoduodenectomy of pancreatobiliary-type adenocarcinomas"}, {"pubmed": 20516147, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20516147, "text": "These results suggest that genetic variants in MAD1L1 and MAD2L1 confer susceptibility to lung cancer."}, {"pubmed": 20624899, "text": "Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex."}, {"pubmed": 20643875, "text": "Findings strongly suggest that the loss of spindle assembly checkpoint proteins, such as Bub1 and Mad2, may cause spontaneous miscarriages."}, {"pubmed": 20923822, "text": "Observational study and genome-wide association study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 21041666, "text": "Mad2 phosphorylation inhibits its function through differentially regulating its binding to Mad1 and Cdc20 and establish that the conformational change of Mad2 is regulated by posttranslational mechanisms."}, {"pubmed": 21046120, "text": "There was a significant positive correlation between hsMAD2 mRNA expression and the sensitivity to paclitaxel in four neuroblastoma cell lines. High hsMAD2 expression may be correlated with paclitaxel-induced apoptosis."}, {"pubmed": 21063845, "text": "Weakened spindle checkpoint with reduced expression of Mad2 is associated with resistance to paclitaxel in ovarian cells."}, {"pubmed": 21335556, "text": "Orderly inactivation of the key checkpoint protein mitotic arrest deficient 2 (MAD2) during mitotic progression"}, {"pubmed": 21376419, "text": "overexpression predicts clinical outcome in primary lung cancer patients"}, {"pubmed": 21472690, "text": "this study suggests that evaluation of BUBR1, MAD2 and Aurora A expression levels is likely to improve accuracy of prognostic predictions in invasive ductal breast carcinoma"}, {"pubmed": 21525009, "text": "BUBR1 and closed MAD2 (C-MAD2) interact directly to assemble a functional mitotic checkpoint complex"}, {"pubmed": 21575600, "text": "These data support a critical role for CHFR in the MAD2 spindle checkpoint."}, {"pubmed": 21665145, "text": "Mad2 is also repressed by p53 and its upregulation is required for chromosome instability in a p53 mutant tumor model"}, {"pubmed": 21751967, "text": "Data show that dasatinib significantly inhibited oesophageal carcinoma cell invasion and up-regulation of MAD2 (mitotic arrest-deficient 2), as well as inducing cell apoptosis and cell-cycle arrest."}, {"pubmed": 21772247, "text": "Mad2 requires association with Mad1 to adopt the closed conformation. The Mad1:C-Mad2 complex is regulated by p31comet-dependent 'capping'. Mad1:C-Mad2 acts as a template to sustain the SAC. It challenges the distinction between SAC & mitotic timer."}, {"pubmed": 22037211, "text": "The mitotic Checkpoint Complex is assembled by first forming a BUBR1:BUB3:CDC20 complex in G2 and then selectively incorporating MAD2 in the closed conformation during mitosis."}, {"pubmed": 22069160, "text": "Loss of MAD2 protein expression results in increased resistance to paclitaxel and reduced progression-free survival in high grade serous epithelial ovarian cancer."}, {"pubmed": 22100920, "text": "p31(comet) negatively regulates the spindle assembly checkpoint by extracting Mad2 from the MCC."}, {"pubmed": 22170163, "text": "Finally, our results provides an explanation of how a p53 controlled pathway, involving initially p21(waf1) and then p14ARF, could minimize the occurrence of genomic alterations derived from chromosome instability induced by low amounts of MAD2 protein"}, {"pubmed": 22405866, "text": "The data reveal a new function for Mad2 to stabilize kinetochore-microtubule (k-MT) attachments independent of the mitotic checkpoint and explain why Mad2 overexpression increases chromosome missegregation to cause chromosomal instability in human tumors."}, {"pubmed": 22797604, "text": "MAD2 expression levels can indicate sensitivity to anticancer agents, and risk for recurrence in ovarian serous adenocarcinoma."}, {"pubmed": 22869558, "text": "The germline transmission of exonic deletion of MAD2 is possibly associated with its loss of expression resulting in abnormal spindle assembly checkpoint function, subsequent aneuploidy and pregnancy loss."}, {"pubmed": 22992948, "text": "data validate the correlation between upregulation of Mad2 and osteosarcoma advancement, and that the underlying mechanisms involve the increase of invasiveness and cancer stem cell properties"}, {"pubmed": 23007648, "text": "The Mad2 and the APC/C competed for Cdc20 in vitro, and a Cdc20 mutant that does not bind stably to Mad2 abrogated the SAC in vivo."}, {"pubmed": 23454898, "text": "Mad2 protein is co-localizes and associated with chk1 increase after DNA damage."}, {"pubmed": 23791783, "text": "Mad2 Binding Induces a Functional Switch in Cdc20,Enabling BubR1 Binding."}, {"pubmed": 23995871, "text": "increased expression of CDC20 and MAD2 is related to poor prognosis of urothelial carcinoma of the human bladder"}, {"pubmed": 24151075, "text": "sustained MPS1 activity is required for maintaining both the MAD1.C-MAD2 complex and open MAD2 (O-MAD2) at unattached kinetochores to facilitate C-MAD2 production"}, {"pubmed": 24344181, "text": "Tpr is a kinetochore-independent, rate-limiting factor required to mount and sustain a robust SAC response."}, {"pubmed": 24425774, "text": "results strongly suggest that PP2A is a good therapeutic target in Mad2-overexpressing tumors"}, {"pubmed": 24491803, "text": "MiR-28-5p is a critical regulator of Mad2 translation and mitotic checkpoint function."}, {"pubmed": 24581499, "text": "Results show that Mad1-Mad2 must be targeted to nuclear pore complexes (NPCs) in order to produce the premitotic Cdc20 inhibitor, which ensures that anaphase and mitotic exit are robustly coupled to the establishment and correction of kinetochore-microtubule attachments."}, {"pubmed": 24596092, "text": "attenuating the affinity of p31(Comet) for Mad2 by phosphorylation promotes SAC activity in mitosis. Specifically, phosphorylation of Ser-102 weakens p31(Comet)-Mad2 binding and enhances p31(Comet)-mediated bypass of the SAC."}, {"pubmed": 24654460, "text": "Studied the significance of budding uninhibited by benzimidazoles-1 (Bub1) and mitotic arrest deficient-2 (Mad2) expression in endometrial carcinoma."}, {"pubmed": 24687487, "text": "Co-depletion of MAD2 and BUBR1 causes cell cycle arrest and cell death in addition to aneuploidy."}, {"pubmed": 24690997, "text": "The interconversion between two distinct conformations of open- and closed-states might facilitate the functional activity of the Mad2 protein."}, {"pubmed": 24711138, "text": "Results showed that neither variants in BUB3 nor variants in MAD2L1 caused any significant effect on the risk of breast cancer"}, {"pubmed": 24724894, "text": "This article reviews Mad1 and Mad2 - structural and functional relationship with implication in genetic diseases, specifically in cancer. [review]"}, {"pubmed": 24747134, "text": "The expression and localization of Mad2 and Cdc20 is regulated by subcellular Chk1 during the metaphase-anaphase transition."}, {"pubmed": 24792619, "text": "In ovarian carcinoma, tumors showing reduced nuclear MAD2 intensity identifying patients with a poorer recurrence-free survival prognosis."}, {"pubmed": 25083970, "text": "MAD2 and CDC20 overexpression was increased in high-grade squamous intraepithelial lesions and squamous cell carcinomas, suggesting their involvement in the initiation of cervical cancers."}, {"pubmed": 25232865, "text": "WT1 has a role in interacting MAD2 and regulating mitotic checkpoint function"}, {"pubmed": 25422469, "text": "the interaction of FAT10 with MAD2 is a key mechanism underlying the promalignant property of FAT10"}, {"pubmed": 25483095, "text": "In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for gastric cancer ."}, {"pubmed": 25503128, "text": "MAD2 may be involved in oral carcinogenesis and may represent an important prognostic factor associated with a more malignant phenotype of oral squamous cell carcinoma."}, {"pubmed": 25637637, "text": "CDC20, MAD2 and Aurora-B protein expression are associated with chromosomal abnormalities and poor prognosis in patients with myelodysplastic syndromes."}, {"pubmed": 25754611, "text": "we showed that BubR1 and Mad2 are overexpressed in oral squamous cell carcinoma cell lines and linked such overexpression to attenuated spindle assembly checkpoint activity."}, {"pubmed": 25898113, "text": "We also show that replication perturbations result in relocalization of MAD1/MAD2 in human cells, suggesting that the role of SAC in DNA repair is conserved."}, {"pubmed": 26183163, "text": "MAD1L1 Arg558His and MAD2L1 Leu84Met interaction with smoking increase the risk of colorectal cancer"}, {"pubmed": 26287798, "text": "MAD2L1 and BUB1 may play important roles in breast cancer progression, and measuring the expression of these genes may assist the prediction of breast cancer prognosis."}, {"pubmed": 26305957, "text": "Data indicate the structure of the intermediate conformer of the multistate checkpoint protein mitotic arrest deficient 2 (Mad2) protein."}, {"pubmed": 26489879, "text": "Studied the folding/unfolding process of the open and closed conformers of human Mad2."}, {"pubmed": 26544187, "text": "p31comet-induced cell death is mediated by interactions with Mad2"}, {"pubmed": 27077767, "text": "Aberrant Mad2 expression was associated with cell proliferation and genetic instability, which may contribute to the carcinogenesis of PGI-DLBCL. Mad2 overexpression indicated a poor DFS."}, {"pubmed": 27198228, "text": "interactions between Mad2 and H3K4 regulate resolution of the spindle assembly checkpoint by limiting closed Mad2 availability for Cdc20 inhibition."}, {"pubmed": 27315568, "text": "Overexpression of MAD2gamma may play a role in checkpoint disruption and is associated with resistance to cisplatin-based chemotherapy in testicular germ cell tumors."}, {"pubmed": 27341405, "text": "in addition to its role in checkpoint signaling, MAD2 ensures chromosome stability through the regulation of AURORA B."}, {"pubmed": 27835911, "text": "this study shows that MAD2L1 is a prognostic biomarker for lung adenocarcinoma"}, {"pubmed": 28102834, "text": "catalytic activation of the spindle assembly checkpoint depends on regulated protein-protein interactions that accelerate the spontaneous but rate-limiting conversion of MAD2 required for mitotic checkpoint complex assembly"}, {"pubmed": 28112196, "text": "we demonstrate that the CDC20-MAD2 complex could also be formed independently of the SAC. Moreover, in prolonged arrest caused by nocodazole treatment, the overall levels of the CDC20-MAD2 complex are gradually, but significantly, reduced and this is associated with lower levels of cyclin B1, which brings a new insight into the mechanism of mitotic \"slippage\" of the arrested cells."}, {"pubmed": 28564602, "text": "These results identify an unexpected dependency on TRIP13 in cells overexpressing Mad2."}, {"pubmed": 28609841, "text": "MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma by suppressing MAD2L1 expression."}, {"pubmed": 28659378, "text": "Thes authors show that p31(comet) binding to the TRIP13 N-terminal domain positions the disordered MAD2 N-terminus for engagement by the TRIP13 \"pore loops\", which then unfold MAD2 in the presence of ATP."}, {"pubmed": 28678347, "text": "TRAP1 is relevant in the control of key cell cycle regulators in tumor cells. TRAP1/TBP7 quality control of CDK1 and MAD2 contributes mechanistically to the regulation of mitotic entry and transit."}, {"pubmed": 28807937, "text": "Low MAD2L1 expression is associated with Chromophobe Renal Cell Carcinomas."}, {"pubmed": 29408509, "text": "MAD2-p31(comet) axis may serve as a potential therapeutic target for glioma."}, {"pubmed": 29555820, "text": "we took advantage of a chemical and chemical-genetic approach to specifically inhibit Aurora A kinase activity in late prometaphase. We observed that a loss of Aurora A activity directly affects SAC function, that Aurora A is essential for maintaining the checkpoint protein Mad2 on unattached kinetochores and that inhibition of Aurora A leads to loss of the SAC, even in the presence of nocodazole or Taxol."}, {"pubmed": 29973720, "text": "study provides insights into how specific substrates are recruited to AAA+ ATPases (like TRIP13) through adaptor proteins and suggests a model of how translocation through the axial pore of AAA+ ATPases is coupled to protein remodelling"}, {"pubmed": 30346937, "text": "MAD2 was found both in SCLC and NSCLC. Interestingly, there was a significant difference found between SCLC and NSCLC using qt-PCR (P<0.05)."}, {"pubmed": 30448220, "text": "MAD2 and CDC20 are the most expressed in high grade dysplasia, suggesting their roles in the early stage of gastric carcinogenesis, whereas their overexpressions in gastric cancer are associated with intestinal histology and favorable clinicopathological parameters, which may be useful for immunohistochemical classification of chromosomal instability-type gastric cancer."}, {"pubmed": 31523901, "text": "Downregulation of Mad2 and BubR1 increase the malignant behavior and nocodazole resistance of SiHa cells via causing spindle assembly checkpoint defect."}, {"pubmed": 31545428, "text": "the present study revealed that PTEN knockdown resulted in MAD2 degradation via the ubiquitinproteasomal pathway, while restoration of MAD2 expression partially ameliorated the mitotic defects induced by PTEN loss."}, {"pubmed": 32029899, "text": "Mitotic slippage is determined by p31(comet) and the weakening of the spindle-assembly checkpoint."}, {"pubmed": 32066746, "text": "Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia."}, {"pubmed": 32322060, "text": "human shugoshin 2, an essential protector of meiotic cohesin with unknown functions in the soma, is turned into a separase inhibitor upon association with spindle assembly checkpoint-activated MAD2"}, {"pubmed": 32795325, "text": "Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development."}, {"pubmed": 32863948, "text": "Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines."}, {"pubmed": 33158996, "text": "BRCA1/MAD2L1 Deficiency Disrupts the Spindle Assembly Checkpoint to Confer Vinorelbine Resistance in Mesothelioma."}, {"pubmed": 34728029, "text": "[Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma]."}, {"pubmed": 34788140, "text": "MAD2L1 Functions As a Novel Diagnostic and Predictive Biomarker in Cholangiocarcinoma."}, {"pubmed": 34999251, "text": "Association of mitotic checkpoint regulator MAD2L1 with fibrosis progression in chronic hepatitis C patients."}, {"pubmed": 35132379, "text": "Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis."}, {"pubmed": 35143103, "text": "Targeting of MAD2L1 by miR-515-5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells."}, {"pubmed": 35305591, "text": "Single-cell sequencing reveals MYC targeting gene MAD2L1 is associated with prostate cancer bone metastasis tumor dormancy."}, {"pubmed": 35384228, "text": "Mad2 promotes Cyclin B2 recruitment to the kinetochore for guiding accurate mitotic checkpoint."}, {"pubmed": 36247080, "text": "Inhibition of MAD2L1 Mediates Pulmonary Fibrosis through Impairment of Mitochondrial Function and Induction of Cell Senescence."}, {"pubmed": 36599972, "text": "MAD2L1 is transcriptionally regulated by TEAD4 and promotes cell proliferation and migration in colorectal cancer."}, {"pubmed": 36637946, "text": "Upregulation of MAD2L1 mediated by ncRNA axis is associated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma: A review."}, {"pubmed": 36781502, "text": "The positive feedback loop of MAD2L1/TYK2/STAT3 induces progression in B-cell acute lymphoblastic leukaemia."}, {"pubmed": 37468549, "text": "CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma."}, {"pubmed": 37752233, "text": "MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex."}, {"pubmed": 38698201, "text": "Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis."}], "genomic_pos": {"chr": "4", "end": 120066858, "ensemblgene": "ENSG00000164109", "start": 120055623, "strand": -1}, "genomic_pos_hg19": {"chr": "4", "end": 120988229, "start": 120976763, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0000070", "qualifier": "involved_in", "term": "mitotic sister chromatid segregation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0000132", "pubmed": 23509069, "qualifier": "involved_in", "term": "establishment of mitotic spindle orientation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007094", "qualifier": "involved_in", "term": "mitotic spindle assembly checkpoint signaling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0007094", "pubmed": 18981471, "qualifier": "involved_in", "term": "mitotic spindle assembly checkpoint signaling"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0007094", "pubmed": 11535616, "qualifier": "involved_in", "term": "mitotic spindle assembly checkpoint signaling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0042177", "pubmed": 11459825, "qualifier": "involved_in", "term": "negative regulation of protein catabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043066", "pubmed": 20870947, "qualifier": "involved_in", "term": "negative regulation of apoptotic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045930", "pubmed": 21274008, "qualifier": "acts_upstream_of_or_within", "term": "negative regulation of mitotic cell cycle"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051301", "qualifier": "involved_in", "term": "cell division"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0051660", "pubmed": 23509069, "qualifier": "involved_in", "term": "establishment of centrosome localization"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0090267", "pubmed": [8824189, 22898774], "qualifier": "involved_in", "term": "positive regulation of mitotic cell cycle spindle assembly checkpoint"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0090267", "pubmed": 20870947, "qualifier": "involved_in", "term": "positive regulation of mitotic cell cycle spindle assembly checkpoint"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1904667", "pubmed": 11459825, "qualifier": "involved_in", "term": "negative regulation of ubiquitin protein ligase activity"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0000776", "qualifier": "is_active_in", "term": "kinetochore"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0000776", "pubmed": [17363900, 19468067], "qualifier": "colocalizes_with", "term": "kinetochore"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0000776", "pubmed": [8824189, 19229290, 20133940], "qualifier": "located_in", "term": "kinetochore"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0000922", "qualifier": "located_in", "term": "spindle pole"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": [18981471, 19010891, 20870947], "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "is_active_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "pubmed": 18981471, "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IPI", "gocategory": "CC", "id": "GO:0033597", "pubmed": 27509861, "qualifier": "part_of", "term": "mitotic checkpoint complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0044615", "pubmed": 18981471, "qualifier": "part_of", "term": "nuclear pore nuclear basket"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0048471", "pubmed": [8824189, 20870947], "qualifier": "located_in", "term": "perinuclear region of cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0072686", "pubmed": 20133940, "qualifier": "located_in", "term": "mitotic spindle"}, {"evidence": "IPI", "gocategory": "CC", "id": "GO:1990728", "pubmed": 12006501, "qualifier": "part_of", "term": "mitotic spindle assembly checkpoint MAD1-MAD2 complex"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [10200259, 10527948, 10700282, 12006501, 15182668, 15525512, 16189514, 16525508, 17443180, 17443186, 18022367, 18022368, 18318601, 18692475, 18794143, 18981471, 19010891, 19143472, 19273613, 19615732, 20133940, 20212161, 20360068, 20951947, 21041666, 21300909, 21407176, 21666598, 21772247, 21988832, 22000412, 22340593, 22493223, 24581499, 25383541, 25416956, 25422469, 25502805, 25852190, 26258632, 26496610, 28514442, 29997244, 31467278, 31515488, 32296183, 32814053, 37398436, 37926298], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": [16525508, 18022367, 18318601, 21041666, 21772247], "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042803", "pubmed": 18022367, "qualifier": "enables", "term": "protein homodimerization activity"}]}, "homologene": {"genes": [[3702, 822195], [4530, 4336215], [4896, 2540589], [4932, 853422], [5141, 3876188], [6239, 177046], [7165, 1272340], [7227, 38656], [7955, 550434], [8364, 100125170], [9031, 422675], [9544, 708574], [9598, 461661], [9606, 4085], [9615, 476070], [9913, 337870], [10090, 56150], [10116, 297176], [28985, 2892732], [33169, 4619571], [318829, 2678561]], "id": 1768}, "interpro": [{"desc": "HORMA domain", "id": "IPR003511", "short_desc": "HORMA_dom"}, {"desc": "HORMA domain superfamily", "id": "IPR036570", "short_desc": "HORMA_dom_sf"}, {"desc": "Mad2-like", "id": "IPR045091", "short_desc": "Mad2-like"}], "ipi": ["IPI00012369", "IPI00877695", "IPI00964981"], "map_location": "4q27", "name": "mitotic arrest deficient 2 like 1", "other_names": ["MAD2 (mitotic arrest deficient, yeast, homolog)-like 1", "MAD2 mitotic arrest deficient-like 1", "MAD2-like protein 1", "mitotic arrest deficient 2-like protein 1", "mitotic arrest deficient, yeast, homolog-like 1", "mitotic spindle assembly checkpoint protein MAD2A"], "pantherdb": {"HGNC": "6763", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1860374", "ortholog_type": "LDO", "panther_family": "PTHR11842", "taxid": 10090, "uniprot_kb": "Q9Z1B5"}, {"RGD": "1310889", "ortholog_type": "LDO", "panther_family": "PTHR11842", "taxid": 10116, "uniprot_kb": "D4ACM2"}, {"Ensembl": "ENSGALG00000011967", "ortholog_type": "LDO", "panther_family": "PTHR11842", "taxid": 9031, "uniprot_kb": "A0A1L1RLV7"}, {"ZFIN": "ZDB-GENE-030515-3", "ortholog_type": "LDO", "panther_family": "PTHR11842", "taxid": 7955, "uniprot_kb": "F1QHN1"}, {"WormBase": "WBGene00003161", "ortholog_type": "LDO", "panther_family": "PTHR11842", "taxid": 6239, "uniprot_kb": "Q9NGT3"}, {"FlyBase": "FBgn0035640", "ortholog_type": "LDO", "panther_family": "PTHR11842", "taxid": 7227, "uniprot_kb": "Q9VRQ2"}, {"SGD": "S000003567", "ortholog_type": "LDO", "panther_family": "PTHR11842", "taxid": 4932, "uniprot_kb": "P40958"}, {"PomBase": "SPBC20F10.06", "ortholog_type": "LDO", "panther_family": "PTHR11842", "taxid": 4896, "uniprot_kb": "O14417"}, {"dictyBase": "DDB_G0273201", "ortholog_type": "LDO", "panther_family": "PTHR11842", "taxid": 352472, "uniprot_kb": "Q556Y9"}, {"TAIR": "2092125", "ortholog_type": "LDO", "panther_family": "PTHR11842", "taxid": 3702, "uniprot_kb": "Q9LU93"}], "uniprot_kb": "Q13257"}, "pathway": {"kegg": [{"id": "hsa04110", "name": "Cell cycle - Homo sapiens (human)"}, {"id": "hsa04114", "name": "Oocyte meiosis - Homo sapiens (human)"}, {"id": "hsa04914", "name": "Progesterone-mediated oocyte maturation - Homo sapiens (human)"}, {"id": "hsa05166", "name": "Human T-cell leukemia virus 1 infection - Homo sapiens (human)"}], "netpath": {"id": "Pathway_KitReceptor", "name": "KitReceptor"}, "reactome": [{"id": "R-HSA-141405", "name": "Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components"}, {"id": "R-HSA-141424", "name": "Amplification of signal from the kinetochores"}, {"id": "R-HSA-141430", "name": "Inactivation of APC/C via direct inhibition of the APC/C complex"}, {"id": "R-HSA-141444", "name": "Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-174143", "name": "APC/C-mediated degradation of cell cycle proteins"}, {"id": "R-HSA-174184", "name": "Cdc20:Phospho-APC/C mediated degradation of Cyclin A"}, {"id": "R-HSA-176408", "name": "Regulation of APC/C activators between G1/S and early anaphase"}, {"id": "R-HSA-176409", "name": "APC/C:Cdc20 mediated degradation of mitotic proteins"}, {"id": "R-HSA-176814", "name": "Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins"}, {"id": "R-HSA-179409", "name": "APC-Cdc20 mediated degradation of Nek2A"}, {"id": "R-HSA-179419", "name": "APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint"}, {"id": "R-HSA-194315", "name": "Signaling by Rho GTPases"}, {"id": "R-HSA-195258", "name": "RHO GTPase Effectors"}, {"id": "R-HSA-2467813", "name": "Separation of Sister Chromatids"}, {"id": "R-HSA-2500257", "name": "Resolution of Sister Chromatid Cohesion"}, {"id": "R-HSA-2555396", "name": "Mitotic Metaphase and Anaphase"}, {"id": "R-HSA-453276", "name": "Regulation of mitotic cell cycle"}, {"id": "R-HSA-5663220", "name": "RHO GTPases Activate Formins"}, {"id": "R-HSA-68877", "name": "Mitotic Prometaphase"}, {"id": "R-HSA-68882", "name": "Mitotic Anaphase"}, {"id": "R-HSA-68886", "name": "M Phase"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-69618", "name": "Mitotic Spindle Checkpoint"}, {"id": "R-HSA-69620", "name": "Cell Cycle Checkpoints"}, {"id": "R-HSA-9648025", "name": "EML4 and NUDC in mitotic spindle formation"}, {"id": "R-HSA-9716542", "name": "Signaling by Rho GTPases, Miro GTPases and RHOBTB3"}], "wikipathways": {"id": "WP4240", "name": "Regulation of sister chromatid separation at the metaphase-anaphase transition"}}, "pdb": ["1DUJ", "1GO4", "1KLQ", "1S2H", "2QYF", "2V64", "2VFX", "3GMH", "5KHU", "5LCW", "6F0X", "6TLJ"], "pfam": "PF02301", "pharmgkb": "PA30521", "pharos": {"target_id": 18442, "tdl": "Tbio"}, "pir": "G01942", "prosite": "PS50815", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF252387", "relationship": "is"}, {"id": "GNF252388", "relationship": "is"}, {"id": "GNF252389", "relationship": "is"}, {"id": "GNF252390", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF159380", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF008646", "relationship": "is"}, {"id": "GNF008647", "relationship": "is"}, {"id": "GNF008648", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF105942", "relationship": "is"}, {"id": "GNF145588", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000004.12", "NC_060928.1"], "protein": "NP_002349.1", "rna": "NM_002358.4", "translation": {"protein": "NP_002349.1", "rna": "NM_002358.4"}}, "reporter": {"HG-U133_Plus_2": ["1554768_a_at", "203362_s_at", "236312_at"], "HG-U95Av2": ["1720_at", "1721_g_at", "37282_at"], "HG-U95B": ["46436_at", "55824_at"], "HTA-2_0": "TC04001507.hg.1", "HuEx-1_0": ["2783715", "3538703"], "HuGene-1_1": "8102560", "HuGene-2_1": "16979389"}, "summary": "MAD2L1 is a component of the mitotic spindle assembly checkpoint that prevents the onset of anaphase until all chromosomes are properly aligned at the metaphase plate.  MAD2L1 is related to the MAD2L2 gene located on chromosome 1.  A MAD2 pseudogene has been mapped to chromosome 14. [provided by RefSeq, Jul 2008].", "symbol": "MAD2L1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1416959"}, "unigene": "Hs.591697", "uniprot": {"Swiss-Prot": "Q13257", "TrEMBL": "D6RJE3"}, "wikipedia": {"url_stub": "MAD2L1"}}